Physician profile
Shubhra Ray
NPI 1245278175
$4,192.88
in general payments reported to CMS, 2019-2025
7 companies · $979 in 2025
The $979 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.46 · 2022: $1,248 · 2023: $911 · 2024: $1,031 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560 · Travel and Lodging: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.09 |
| Travel and Lodging | $1,360.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,895.91 | 2022-2025 | Da Vinci Surgical System |
| Galvanize Therapeutics, INC | $75.28 | 2024 | Aliya System |
| Pinnacle Biologics, INC | $61.41 | 2025 | Photofrin |
| Olympus America INC. | $58.71 | 2025 | |
| Edwards Lifesciences Corporation | $39.23 | 2025 | Inspiris Resilia Aortic Valve |
| Ethicon INC. | $37.88 | 2022 | |
| Csl Behring | $24.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shubhra Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.